Patient satisfaction with long-acting injectable buprenorphine: What needs to be measured from the patient’s perspective?

Research output: Contribution to journalArticlepeer-review

4 Downloads (Pure)

Abstract

Background
Long-acting injectable buprenorphine is an effective treatment for opioid use disorder. This paper asks: 1. How satisfied are people with long-acting injectable buprenorphine during their first year of treatment? 2. How do people receiving long-acting injectable buprenorphine assess treatment satisfaction/dissatisfaction? 3. Does long-acting injectable buprenorphine require its own specific satisfaction measure?

Methods
Semi-structured qualitative interviews were conducted with 26 people receiving long-acting injectable buprenorphine. Participants were recruited from community drug treatment services in England and Wales. Data were transcribed, coded, and analyzed via Iterative Categorization.

Results
Patient satisfaction was high and constituted through six domains: 1. Global satisfaction (overall satisfaction, preferred medication); 2. Medication features (dose, injection, knowing what to expect, availability); 3. Effects on substance use (drug consumption, withdrawal symptoms); 4. Effects on substance use treatment (not having to attend services daily, support provided by services); 5. Effects on the self (physical changes, psychological impact); 6. Effects on daily life (employment/studying, interest in other activities, relationships, material possessions, no acquisitive crime).

Conclusions
Satisfaction is a multifaceted construct extending beyond long-acting injectable buprenorphine’s pharmacological properties and encompassing wider life areas. Further research is needed to develop a specific satisfaction measure, but adaptations to clinical practice may improve satisfaction meantime.
Original languageEnglish
JournalDrugs: Education, Prevention and Policy
Early online date26 May 2025
DOIs
Publication statusE-pub ahead of print - 26 May 2025

Keywords

  • Heroin
  • Long-acting injectable buprenorphine
  • Measurement
  • Opioid
  • Qualitative
  • Satisfaction
  • Treatment

Fingerprint

Dive into the research topics of 'Patient satisfaction with long-acting injectable buprenorphine: What needs to be measured from the patient’s perspective?'. Together they form a unique fingerprint.

Cite this